HealthEquity, Inc. (FRA:2HE)
Germany · Delayed Price · Currency is EUR 69.00
+0.50 (0.73%)
At close: Jan 30, 2026
HealthEquity Cash Flow Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 |
Net Income | 191.83 | 96.7 | 55.71 | -26.14 | -44.29 | 8.83 |
Depreciation & Amortization | 155.16 | 162.45 | 153.08 | 161.2 | 137.19 | 115.9 |
Other Amortization | 1.07 | 2.07 | 2.85 | 3.26 | 4.45 | 5.1 |
Asset Writedown & Restructuring Costs | - | - | - | - | 11.25 | - |
Loss (Gain) From Sale of Investments | - | - | - | - | -1.68 | - |
Stock-Based Compensation | 75.65 | 96.43 | 77.15 | 62.61 | 52.75 | 42.86 |
Other Operating Activities | 39.96 | -11.26 | -12.84 | -16.91 | -20.3 | -3.38 |
Change in Accounts Receivable | -4.53 | -13.11 | -8.06 | -9.57 | -11.2 | -0.41 |
Change in Accounts Payable | -27.14 | 8.89 | -0.2 | -26.67 | -2.18 | 30.42 |
Change in Other Net Operating Assets | -17.07 | -2.31 | -24.87 | 2.87 | 15.01 | -17.71 |
Operating Cash Flow | 414.93 | 339.86 | 242.83 | 150.65 | 141 | 181.62 |
Operating Cash Flow Growth | 21.62% | 39.96% | 61.19% | 6.85% | -22.37% | 72.95% |
Capital Expenditures | -1.97 | -2.08 | -1.69 | -3.37 | -8.91 | -13.09 |
Cash Acquisitions | - | - | - | - | -504.53 | - |
Sale (Purchase) of Intangibles | -50.29 | -503.37 | -44.38 | -115.76 | -128.17 | -83.87 |
Investment in Securities | - | - | - | - | 2.37 | - |
Investing Cash Flow | -52.26 | -505.45 | -46.07 | -119.13 | -639.25 | -96.96 |
Long-Term Debt Issued | - | 736.88 | - | - | 950 | - |
Long-Term Debt Repaid | - | -561.88 | -54.38 | -8.75 | -1,003 | -239.06 |
Net Debt Issued (Repaid) | -100 | 175 | -54.38 | -8.75 | -53.13 | -239.06 |
Issuance of Common Stock | 9.83 | 9.43 | 6.47 | 6.68 | 466.39 | 295.35 |
Repurchase of Common Stock | -281.21 | -121.49 | - | - | - | - |
Other Financing Activities | -4.19 | -5.37 | 0.87 | -0.6 | -18.41 | -3.86 |
Financing Cash Flow | -375.57 | 57.57 | -47.04 | -2.67 | 394.86 | 52.42 |
Net Cash Flow | -12.9 | -108.03 | 149.71 | 28.85 | -103.39 | 137.08 |
Free Cash Flow | 412.96 | 337.77 | 241.13 | 147.28 | 132.09 | 168.53 |
Free Cash Flow Growth | 21.86% | 40.08% | 63.73% | 11.50% | -21.62% | 72.45% |
Free Cash Flow Margin | 32.00% | 28.15% | 24.12% | 17.09% | 17.46% | 22.97% |
Free Cash Flow Per Share | 4.68 | 3.80 | 2.77 | 1.74 | 1.59 | 2.23 |
Cash Interest Paid | 54.84 | 58.59 | 49.56 | 43.57 | 16.11 | 27.69 |
Cash Income Tax Paid | 9.6 | 26.07 | 35.35 | 1.53 | -5.63 | -6.02 |
Levered Free Cash Flow | 279.54 | -145.32 | 211.89 | 69.65 | 69.7 | 97 |
Unlevered Free Cash Flow | 315.42 | -109.49 | 243.69 | 96.65 | 88.11 | 113.7 |
Change in Working Capital | -48.74 | -6.53 | -33.13 | -33.37 | 1.63 | 12.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.